Drugstore chain Cosmed’s (康是美) revenue is expected to grow 10 percent to nearly NT$11 billion (US$349 million) this year, supported by the introduction of more concept stores and renovation of existing outlets, president Martin Chang (張聰本) told a news conference yesterday.
The concept stores, which feature more global cosmetic brands, are in line with its strategy of transforming its image from that of a drugstore to a “beauty store,” Chang said.
The strategy, which is aimed at differentiating it from rivals in the market, has helped boost customer traffic and average customer spending, he said.
Cosmed yesterday also introduced its eighth concept shop, which opened in Taichung.
Cosmed operates 390 outlets across the nation, including eight concept stores.
The company also aims to upgrade its stores by renovating buildings and adjusting product displays, it said.
The company hopes to renovate all its outlets in two years, Chang said.
He added that stores would be adjusting their product portfolios based on market demand.
Cosmed, a subsidiary of President Chain Store Corp (統一超商), is the nation’s second-largest drug store chain operator after Watson’s Personal Care Stores (Taiwan) Co (台灣屈臣氏).
Zhang Yazhou was sitting in the passenger seat of her Tesla Model 3 when she said she heard her father’s panicked voice: The brakes do not work. Approaching a red light, her father swerved around two cars before plowing into a sport utility vehicle and a sedan, and crashing into a large concrete barrier. Stunned, Zhang gazed at the deflating airbag in front of her. She could never have imagined what was to come: Tesla Inc sued her for defamation for complaining publicly about the vehicles brakes — and won. A Chinese court ordered Zhang to pay more than US$23,000 in
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday held its first board of directors meeting in the US, at which it did not unveil any new US investments despite mounting tariff threats from US President Donald Trump. Trump has threatened to impose 100 percent tariffs on Taiwan-made chips, prompting market speculation that TSMC might consider boosting its chip capacity in the US or ramping up production of advanced chips such as those using a 2-nanometer technology process at its Arizona fabs ahead of schedule. Speculation also swirled that the chipmaker might consider building its own advanced packaging capacity in the US as part
‘NO DISRUPTION’: A US trade association said that it was ready to work with the US administration to streamline the program’s requirements and achieve shared goals The White House is seeking to renegotiate US CHIPS and Science Act awards and has signaled delays to some upcoming semiconductor disbursements, two sources familiar with the matter told reporters. The people, along with a third source, said that the new US administration is reviewing the projects awarded under the 2022 law, meant to boost US domestic semiconductor output with US$39 billion in subsidies. Washington plans to renegotiate some of the deals after assessing and changing current requirements, the sources said. The extent of the possible changes and how they would affect agreements already finalized was not immediately clear. It was not known
US President Donald Trump has threatened to impose up to 100 percent tariffs on Taiwan’s semiconductor exports to the US to encourage chip manufacturers to move their production facilities to the US, but experts are questioning his strategy, warning it could harm industries on both sides. “I’m very confused and surprised that the Trump administration would try and do this,” Bob O’Donnell, chief analyst and founder of TECHnalysis Research in California, said in an interview with the Central News Agency on Wednesday. “It seems to reflect the fact that they don’t understand how the semiconductor industry really works,” O’Donnell said. Economic sanctions would
RSS